ABSTRACT
Efflux pumps are active transporters, which allow the cell to remove toxic substances from within the cell including antibiotics and photosensitizer complexes. Efflux pump inhibitors (EPIs), chemicals that prevent the passage of molecules through efflux pumps, play a crucial role in antimicrobial effectiveness against pathogen. In this work, we studied the effect of EPI, namely, reserpine, on photodeactivation rate of pathogens when used with Ag NPs and methylene blue (MB). Our results show that using reserpine led to a higher deactivation rate than Ag NPs and MB alone. The mechanism of this observation was investigated with singlet oxygen generation amount. Additionally, different sizes of Ag NPs were tested with reserpine. Molecular docking calculation shows that reserpine had higher affinity toward AcrB than MB. The improvement in bacterial deactivation rate is attributed to blockage of the AcrAB-TolC efflux pump preventing the removal of MB rather than enhanced singlet oxygen production. These results suggest that using reserpine with nanoparticles and photosynthesize is a promising approach in photodynamic therapy.
Subject(s)
Metal Nanoparticles , Methylene Blue , Molecular Docking Simulation , Photochemotherapy , Photosensitizing Agents , Reserpine , Silver , Singlet Oxygen , Photochemotherapy/methods , Photosensitizing Agents/pharmacology , Methylene Blue/pharmacology , Silver/pharmacology , Silver/chemistry , Reserpine/pharmacology , Metal Nanoparticles/chemistry , Singlet Oxygen/metabolism , Escherichia coli/drug effectsABSTRACT
Photodynamic therapy (PDT) is a field with many applications including chemotherapy. Graphene quantum dots (GQDs) exhibit a variety of unique properties and can be used in PDT to generate singlet oxygen that destroys pathogenic bacteria and cancer cells. The PDT agent, methylene blue (MB), like GQDs, has been successfully exploited to destroy bacteria and cancer cells by increasing reactive oxygen species generation. Recently, combinations of GQDs and MB have been shown to destroy pathogenic bacteria via increased singlet oxygen generation. Here, we performed a spectrophotometric assay to detect and measure the uptake of GQDs, MB and several GQD-MB combinations in MCF-7 breast cancer cells. Then, we used a cell counting method to evaluate the cytotoxicity of GQDs, MB and a 1:1 GQD:MB preparation. Singlet oxygen generation in cells was then detected and measured using singlet oxygen sensor green. The dye, H2 DCFDA, was used to measure reactive oxygen species production. We found that GQD and MB uptake into MCF-7 cells occurred, but that MB, followed by 1:1 GQD:MB, caused superior cytotoxicity and singlet oxygen and reactive oxygen species generation. Our results suggest that methylene blue's effect against MCF-7 cells is not potentiated by GQDs, either in light or dark conditions.
Subject(s)
Breast Neoplasms/drug therapy , Breast Neoplasms/radiotherapy , Graphite/chemistry , Photochemotherapy/methods , Quantum Dots/chemistry , Sulfur/chemistry , Cell Survival/drug effects , Cell Survival/radiation effects , Female , Humans , MCF-7 Cells , Methylene Blue/chemistry , Methylene Blue/pharmacology , Photosensitizing Agents/pharmacology , Spectrometry, FluorescenceABSTRACT
Due to their many unique properties, graphene quantum dots (GQDs) have attracted much attention and are a promising material with potential applications in many fields. One application of GQDs is as a photodynamic therapy agent that generates singlet oxygen. In this work, GQDs were grown by focusing nanosecond laser pulses into benzene and then were later combined with methylene blue (MB) and used to eradicate the Gram-negative bacteria, Escherichia coli, and Gram-positive bacteria, Micrococcus luteus. Theoretical calculation of pressure evolution was calculated using the standard finite difference method. Detailed characterization was performed with transmission electron microscopy (TEM), scanning electron microscopy (SEM), Fourier-transform infrared (FTIR), UV-vis (UV-vis), and photoluminescence (PL) spectra. Furthermore, MB-GQD singlet oxygen generation was investigated by measuring the rate of 9,10-anthracenediyl-bis(methylene) dimalonic acid photobleaching. Combining MB with GQDs caused enhanced singlet oxygen generation. Our results show that the MB-GQD combination efficiently destroys bacteria. The (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (MTT) assay was used to determine if GQDs in dark conditions caused human cellular side-effects and affected cancer and noncancer cellular viability. We found that even high concentrations of GQDs do not alter viability under dark conditions. These results suggest that the MB-GQD combination is a promising form of photodynamic therapy.
Subject(s)
Graphite/chemistry , Low-Level Light Therapy/methods , Methylene Blue/therapeutic use , Quantum Dots/therapeutic use , Singlet Oxygen/agonists , Sulfur Compounds/therapeutic use , Cell Survival/radiation effects , Lasers, Solid-State , Methylene Blue/administration & dosage , Quantum Dots/administration & dosage , Sulfur Compounds/administration & dosageABSTRACT
The photo-inactivation rate of bacteria by methylene blue, MB, was found to be significantly lower in plasma than in water, saline, and PBS solutions. The spectroscopic data and ultrafast time resolved transient spectra and kinetics presented show that methylene blue photo-bleaches faster and to a larger degree in plasma and the MB excited singlet and triplet state populations in plasma are much lower in plasma than in water and PBS solutions. The optical density, OD, of MB in plasma was found to decrease by ~50% after a minute of illumination with 661 nm light, while under identical conditions the OD in PBS solution decreased by only 1%. Based on these data and the effect of the plasma proteins on MB photochemistry, a mechanism is proposed that accounts for the low inactivation rate of bacteria in plasma.
